These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8581860)

  • 61. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus.
    Zimmer GM; Wentink GH; Bruschke C; Westenbrink FJ; Brinkhof J; de Goey I
    Vet Microbiol; 2002 Nov; 89(4):255-65. PubMed ID: 12383635
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.
    Wang L; Sunyer JO; Bello LJ
    J Virol; 2004 Feb; 78(4):1616-22. PubMed ID: 14747527
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of oral meloxicam and long-distance transport on cell-mediated and humoral immune responses in feedlot steers receiving modified live BVDV booster vaccination on arrival.
    Van Engen NK; Platt R; Roth JA; Stock ML; Engelken T; Vann RC; Wulf LW; Busby WD; Wang C; Kalkwarf EM; Coetzee JF
    Vet Immunol Immunopathol; 2016 Jul; 175():42-50. PubMed ID: 27269791
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis of naturally occurring bovine viral diarrhea virus infections in ruminants using monoclonal antibody-based immunohistochemistry.
    Baszler TV; Evermann JF; Kaylor PS; Byington TC; Dilbeck PM
    Vet Pathol; 1995 Nov; 32(6):609-18. PubMed ID: 8592795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bovine viral diarrhoea virus serology: antibody response after vaccination.
    Allock J
    Vet Rec; 2001 Feb; 148(7):220. PubMed ID: 11266009
    [No Abstract]   [Full Text] [Related]  

  • 67. Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody.
    Howard CJ; Clarke MC; Brownlie J
    Vet Microbiol; 1989 Mar; 19(3):195-203. PubMed ID: 2541531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. "Self" and "nonself" manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells.
    Schweizer M; Mätzener P; Pfaffen G; Stalder H; Peterhans E
    J Virol; 2006 Jul; 80(14):6926-35. PubMed ID: 16809298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell-mediated and humoral immune responses to bovine herpesvirus type 1 and bovine viral diarrhea virus in calves following administration of a killed-virus vaccine and bovine herpesvirus type 1 challenge.
    Van Anne TR; Rinehart CL; Buterbaugh RE; Bauer MJ; Young AJ; Blaha ML; Klein AL; Chase CCL
    Am J Vet Res; 2018 Nov; 79(11):1166-1178. PubMed ID: 30372148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I.
    Beer M; Hehnen HR; Wolfmeyer A; Poll G; Kaaden OR; Wolf G
    Vet Microbiol; 2000 Nov; 77(1-2):195-208. PubMed ID: 11042413
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A bovine virus diarrhea calfhood vaccination trial in a persistently infected herd: effects on titres, health and growth.
    Ernst PB; Butler DG
    Can J Comp Med; 1983 Apr; 47(2):118-23. PubMed ID: 6309345
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bovine viral diarrhea virus-infected MDBK monolayer as antigen in enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies in bovine sera.
    Justewicz DM; Magar R; Marsolais G; Lecomte J
    Vet Immunol Immunopathol; 1987 Apr; 14(4):377-84. PubMed ID: 3037768
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes.
    Carlsson U; Alenius S; Sundquist B
    Vaccine; 1991 Aug; 9(8):577-80. PubMed ID: 1663302
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of a neutralising antibody response to an inoculated cytopathic strain of bovine virus diarrhoea virus.
    Westenbrink F; Straver PJ; Kimman TG; de Leeuw PW
    Vet Rec; 1989 Sep; 125(10):262-5. PubMed ID: 2552639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transient elimination of circulating bovine viral diarrhoea virus by colostral antibodies in persistently infected calves: a pitfall for BVDV-eradication programs?
    Fux R; Wolf G
    Vet Microbiol; 2012 Dec; 161(1-2):13-9. PubMed ID: 22824254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Production of cattle immunotolerant to bovine viral diarrhea virus.
    McClurkin AW; Littledike ET; Cutlip RC; Frank GH; Coria MF; Bolin SR
    Can J Comp Med; 1984 Apr; 48(2):156-61. PubMed ID: 6326980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.